全文获取类型
收费全文 | 3508篇 |
免费 | 208篇 |
国内免费 | 26篇 |
专业分类
耳鼻咽喉 | 53篇 |
儿科学 | 39篇 |
妇产科学 | 41篇 |
基础医学 | 654篇 |
口腔科学 | 20篇 |
临床医学 | 263篇 |
内科学 | 880篇 |
皮肤病学 | 83篇 |
神经病学 | 367篇 |
特种医学 | 138篇 |
外科学 | 354篇 |
综合类 | 16篇 |
一般理论 | 1篇 |
预防医学 | 150篇 |
眼科学 | 51篇 |
药学 | 325篇 |
中国医学 | 32篇 |
肿瘤学 | 275篇 |
出版年
2023年 | 27篇 |
2022年 | 97篇 |
2021年 | 188篇 |
2020年 | 71篇 |
2019年 | 93篇 |
2018年 | 114篇 |
2017年 | 84篇 |
2016年 | 93篇 |
2015年 | 94篇 |
2014年 | 123篇 |
2013年 | 190篇 |
2012年 | 283篇 |
2011年 | 249篇 |
2010年 | 139篇 |
2009年 | 139篇 |
2008年 | 229篇 |
2007年 | 213篇 |
2006年 | 213篇 |
2005年 | 201篇 |
2004年 | 197篇 |
2003年 | 144篇 |
2002年 | 163篇 |
2001年 | 23篇 |
2000年 | 20篇 |
1999年 | 18篇 |
1998年 | 20篇 |
1997年 | 13篇 |
1996年 | 22篇 |
1995年 | 20篇 |
1994年 | 17篇 |
1993年 | 20篇 |
1992年 | 14篇 |
1991年 | 11篇 |
1990年 | 12篇 |
1989年 | 8篇 |
1988年 | 10篇 |
1986年 | 7篇 |
1985年 | 9篇 |
1984年 | 13篇 |
1983年 | 13篇 |
1982年 | 9篇 |
1981年 | 12篇 |
1979年 | 10篇 |
1978年 | 9篇 |
1977年 | 12篇 |
1973年 | 10篇 |
1972年 | 6篇 |
1969年 | 8篇 |
1968年 | 6篇 |
1966年 | 6篇 |
排序方式: 共有3742条查询结果,搜索用时 15 毫秒
941.
Zatloukalová J Svihálková-Sindlerová L Kozubík A Krcmár P Machala M Vondrácek J 《Biochemical pharmacology》2007,73(10):1622-1634
942.
Qin Z Kastrati I Chandrasena RE Liu H Yao P Petukhov PA Bolton JL Thatcher GR 《Journal of medicinal chemistry》2007,50(11):2682-2692
The regulation of estrogenic and antiestrogenic effects of selective estrogen receptor modulators (SERMs) is thought to underlie their clinical use. Most SERMs are polyaromatic phenols susceptible to oxidative metabolism to quinoids, which are proposed to be genotoxic. Conversely, the redox reactivity of SERMs may contribute to antioxidant and chemopreventive mechanisms, providing a new approach to improve the therapeutic properties of SERMs. An improved synthetic strategy was developed to generate a family of benzothiophene SERMs. Using computational modeling methods and measurements of antioxidant activity and estrogen receptor (ER) ligand binding, this SERM family was shown to provide both a range of ERalpha/ERbeta selectivity from 1.2- to 67-fold and a range of redox activity. Antioxidant activity was successfully modulated by varying a substituent remote from the OH group; the source of the antioxidant capacity. An efficient synthetic procedure is reported yielding benzothiophene SERMs wherein redox activity and ER affinity are modulated. 相似文献
943.
Sauerberg P Olsen GS Jeppesen L Mogensen JP Pettersson I Jeppesen CB Daugaard JR Galsgaard ED Ynddal L Fleckner J Panajotova V Polivka Z Pihera P Havranek M Wulff EM 《Journal of medicinal chemistry》2007,50(7):1495-1503
The aim was to identify a novel selective PPARdelta agonist with full efficacy on free fatty acid (FFA) oxidation in vitro and plasma lipid correction in vivo. Using the triple PPARalpha,gamma,delta agonist 1 as the structural starting point, we wanted to investigate the possibility of obtaining selective PPARdelta agonists by modifying only the acidic part of 1, while holding the lipophilic half of the molecule constant. The structure-activity relationship was guided by in vitro transactivation data using the human PPAR receptors, FFA oxidation efficacy performed in the rat muscle L6 cell line, and in vivo rat pharmacokinetic properties. Compound 7 ([4-[3,3-bis-(4-bromo-phenyl)-allylthio]-2-chloro-phenoxy]-acetic acid) was identified as a selective, partial agonist with good oral pharmacokinetic properties in rat. Chronic treatment of high fat fed ApoB100/CETP-Tgn mice with 7 corrected the plasma lipid parameters and improved insulin sensitivity. These data suggest that selective PPARdelta agonists have the potential to become a novel treatment of dyslipidemia. 相似文献
944.
Kostyantyn V Dumchev Ruslan Soldyshev Han-Zhu Qian Olexandr O Zezyulin Susan D Chandler Pavel Slobodyanyuk Larisa Moroz Joseph E Schumacher 《Harm reduction journal》2009,6(1):23-9
Background
Ukraine has experienced an increase in injection drug use since the 1990s. An increase in HIV and hepatitis C virus infections has followed, but not measures of prevalence and risk factors. The purposes of this study are to estimate the prevalence of HIV, HCV, and co-infection among injection drug users (IDUs) in central Ukraine and to describe risk factors for HIV and HCV. 相似文献945.
Structure-Activity–Dependent Regulation of Cell Communication by Perfluorinated Fatty Acids using in Vivo and in Vitro Model Systems
下载免费PDF全文
![点击此处可从《Environmental health perspectives》网站下载免费的PDF全文](/ch/ext_images/free.gif)
Brad L. Upham Joon-Suk Park Pavel Babica Iva Sovadinova Alisa M. Rummel James E. Trosko Akihiko Hirose Ryuichi Hasegawa Jun Kanno Kimie Sai 《Environmental health perspectives》2009,117(4):545-551
Background
Perfluoroalkanoates, [e.g., perfluorooctanoate (PFOA)], are known peroxisome proliferators that induce hepatomegaly and hepatocarcinogenesis in rodents, and are classic non-genotoxic carcinogens that inhibit in vitro gap-junctional intercellular communication (GJIC). This inhibition of GJIC is known to be a function of perfluorinated carbon lengths ranging from 7 to 10.Objectives
The aim of this study was to determine if the inhibition of GJIC by PFOA but not perfluoropentanoate (PFPeA) observed in F344 rat liver cells in vitro also occurs in F344 rats in vivo and to determine mechanisms of PFOA dysregulation of GJIC using in vitro assay systems.Methods
We used an incision load/dye transfer technique to assess GJIC in livers of rats exposed to PFOA and PFPeA. We used in vitro assays with inhibitors of cell signaling enzymes and antioxidants known to regulate GJIC to identify which enzymes regulated PFOA-induced inhibition of GJIC.Results
PFOA inhibited GJIC and induced hepatomegaly in rat livers, whereas PFPeA had no effect on either end point. Serum biochemistry of liver enzymes indicated no cytotoxic response to these compounds. In vitro analysis of mitogen-activated protein kinase (MAPK) indicated that PFOA, but not PFPeA, can activate the extracellular receptor kinase (ERK). Inhibition of GJIC, in vitro, by PFOA depended on the activation of both ERK and phosphatidylcholine-specific phospholipase C (PC-PLC) in the dysregulation of GJIC in an oxidative-dependent mechanism.Conclusions
The in vitro analysis of GJIC, an epigenetic marker of tumor promoters, can also predict the in vivo activity of PFOA, which dysregulated GJIC via ERK and PC-PLC. 相似文献946.
Rabies prevention and appropriate population management of free-ranging animals have an important role to play in the eventual elimination of rabies in dogs. An effective sterilant based on rabies vaccines has the potential to create a supportive measure of public acceptability and to reduce associated clinic visit costs. We inserted the coding sequence of gonadotropin-releasing hormone (GnRH) into different locations within the rabies virus ERA glycoprotein (G) gene, and demonstrated that the amino terminus (N), antigenic site IIa, and the junction between the ecto- and cytoplasmic domains (C) of the G were suitable sites for GnRH insertion. The rescued recombinant rabies viruses ERA-N-GnRH and ERA-C-GnRH grew as well as the parental ERA virus, reaching 1 × 109 ffu/ml in cell culture. Insertion and expression of the GnRH were stable in the viruses after multiple passages in vitro. To increase immunogenicity of the GnRH peptide, two copies of GnRH, aligned in tandem, were fused to the N terminus of the G. The recombinant rabies virus ERA-N-2GnRH was recovered and grown to high titers in cell culture. All GnRH-carrying rabies viruses induced antibodies against GnRH in immunized mice and protected 100% of the animals after rabies virus challenge. The recombinant viruses reacted strongly with the serum from a GonaCon™-immunized animal. The GnRH-carrying rabies viruses have significant potential in rabies and animal population control. 相似文献
947.
Kajsa Lundberg Anna-Karin Roos Maxim Pavlenko Christoph Leder Diana Wehrum José Guevara-Patiño Rikke Sick Andersen Pavel Pisa 《Vaccine》2009
Efficacy of vaccination in cancer patients on immunotherapeutic protocols can be difficult to evaluate. The aim of this study was therefore to identify a single natural or modified epitope in prostate-specific antigen (PSA) with the ability to generate high levels of PSA-specific T cells to facilitate monitoring in patients after vaccination against prostate cancer. To the best of our knowledge, this study describes for the first time the peptide specificity of T cells stimulated by endogenously processed PSA antigen. The peptide specificity of HLA-A*0201-restricted CD8+ T cells against human and rhesus PSA was investigated both in vivo after DNA vaccination in HLA-A*0201-transgenic mice and in vitro after repetitive stimulation of human T cells with DNA-transfected human dendritic cells (DCs). One of seven native PSA peptides, psa53–61, was able to activate high levels of PSA-specific CD8+ T cells in HLA-A*0201-transgenic mice after PSA DNA vaccination. Psa53–61 was also the only peptide that induced human T cells to produce IFNγ after stimulation with PSA transfected DCs, however not in all donors. Therefore, plasmids encoding modified epitopes in predicted HLA-A*0201 sequences were constructed. One of these modified PSA plasmids consistently induced IFNγ producing CD8+ T cells to the corresponding modified peptide as well as to the corresponding native peptide, in all murine and human T cell cultures. This study demonstrates a novel concept of introducing a modified epitope within a self-tumor antigen, with the purpose of eliciting a reliable T cell response from the non-tolerized immune repertoire, to facilitate monitoring of vaccine efficacy in cancer patients on immunotherapeutic protocols. The purpose of such a modified epitope is thus not to induce therapeutically relevant T cells but rather to, in case of weak or divergent T cell responses to self antigens/peptides, help answer questions about efficacy of vaccine delivery and about the possibility to induce immune responses in the selected and often immunosuppressed cancer patients. 相似文献
948.
949.
Eva Lincová Zuzana Pernicová Pavel Kr?má? Alois Kozubík 《Biochemical pharmacology》2009,78(6):561-572
Antitumorigenic effects of non-steroidal anti-inflammatory drugs (NSAIDs) are well established in several types of cancer disease. However, the mechanisms driving these processes are not understood in all details. In our study, we observed significant differences in sensitivity of cancer epithelial cell lines to COX-independent antiproliferative effects of NSAIDs. The prostate cancer cell line LNCaP, lacking both critical enzymes in the negative control of PKB/Akt activation, PTEN and SHIP2, was the most sensitive to these effects, as assessed by analysing the cell cycle profile and expression of cell cycle regulating proteins. We found that p53 protein and its signalling pathway is not involved in early antiproliferative action of the selected NSAID—indomethacin. RNAi provided evidence for the involvement of p21Cip1/Waf1, but not GDF-15, in antiproliferative effects of indomethacin in LNCaP cells. Interestingly, we also found that indomethacin activated PKB/Akt and induced nuclear localisation of p21Cip1/Waf1 and Akt2 isoform. Our results are in agreement with other studies and suggest that maintaining of the p21Cip1/Waf1 level and its intracellular localisation might be influenced by Akt2. Knock-down of SHIP2 by RNAi in PTEN negative prostate and colon cancer cell lines resulted in higher sensitivity to antiproliferative effects of indomethacin. Our data suggest novel mechanisms of NSAIDs antiproliferative action in cancer epithelial cells, which depends on the status of negative regulation of the PKB/Akt pathway and the isoform-specific action of Akt2. Thus, unexpectedly, multiple defects in negative regulation of the PKB/Akt pathway may contribute to increased sensitivity to chemopreventive effects of these widely used drugs. 相似文献
950.
Sponer P Urban K 《Acta medica (Hradec Králové) / Universitas Carolina, Facultas Medica Hradec Králové》2006,49(1):71-73
We reviewed the cases of three patients with an unstable grade-III slipped capital femoral epiphysis treated between 2001 and 2003. Clinical records and imaging studies were reviewed for patient's history, anatomic features of the slip, definitive treatment and clinical outcome. The duration of the follow-up ranged from twenty-four to fourty-eight months. 相似文献